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Abstract: A set of benzimidazole derivatives were tested for their inhibitory activities 
against the Gram-negative bacterium Pseudomonas aeruginosa and minimum inhibitory 
concentrations were determined for all the compounds. Quantitative structure activity 
relationship (QSAR) analysis was applied to fourteen of the abovementioned derivatives 
using a combination of various physicochemical, steric, electronic, and structural 
molecular descriptors. A multiple linear regression (MLR) procedure was used to model 
the relationships between molecular descriptors and the antibacterial activity of the 
benzimidazole derivatives. The stepwise regression method was used to derive the most 
significant models as a calibration model for predicting the inhibitory activity of this 
class of molecules. The best QSAR models were further validated by a leave one out 
technique as well as by the calculation of statistical parameters for the established 
theoretical models. To confirm the predictive power of the models, an external set of 
molecules was used. High agreement between experimental and predicted inhibitory 
values, obtained in the validation procedure, indicated the good quality of the derived 
QSAR models. 
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1. Introduction 
 
The benzimidazoles are a large chemical family used as antimicrobial agents against the wide 
spectrum of microorganisms [1-9]. Because of its synthetic utility and broad range of pharmacological 
effects, the benzimidazole nucleus is an important heterocyclic ring, and interest in the chemistry, 
synthesis and microbiology of this pharmacophore continues to be fuelled by its antifungal [10], 
antitubercular [11], antioxidant [12,13], and antiallergic
 [14,15] properties. Other reports have revealed 
that these molecules are also present in a variety of antiparasitic [16,17] and herbicidal
 agents [18]. 
Albendazole, fenbendazole and their sulphoxide derivatives are methylcarbamate benzimidazoles with 
a broad spectrum anthelmintic activity, widely used in human and veterinary medicine [19]. They are 
used against several systemic parasitoses, including nematodoses, hidatidosis, teniasis and others [20]. 
They are also used to treat microsporodial and cryptosporodial infections, which can cause lethal 
diarrhea in patients treated with immunosuppressive drugs, or infected with HIV [21,22]. 
Different substituted benzimidazolyl quinolinyl mercaptotriazoles are remarkably effective 
compounds both with respect to their virus inhibitory activity and their favourable antibacterial 
activity [23]. In recent years, benzimidazole derivatives have been attracted particular interest due to 
their antiviral activity against HCV (Hepatitis C virus) [24,25]. 
Although a variety of benzimidazole derivatives are known, the development of new and 
convenient strategies to synthesize new biologically active benzimidazoles is of considerable interest. 
Quantitative structure activity relationship (QSAR) studies are useful tools in the rational search for 
bioactive molecules. The main success of the QSAR method is the possibility to estimate the 
characteristics of new chemical compounds without the need to synthesize and test them. This analysis 
represents an attempt to relate structural descriptors of compounds with their physicochemical 
properties and biological activities. This is widely used for the prediction of physicochemical 
properties in the chemical, pharmaceutical, and environmental spheres. This method included data 
collection, molecular descriptor selection, correlation model development, and finally model 
evaluation. QSAR studies have predictive ability and simultaneously provide deeper insight into 
mechanism of drug receptor interactions [26,27]. 
In view of the above and in continuation of our studies on the inhibitory activities of benzimidazole 
derivatives, as well as on correlation of molecular properties with activity [4-8,28-35], the objective of 
this investigation was to study the usefulness of QSAR in the prediction of the antibacterial activity of 
benzimidazole derivatives against Pseudomonas aeruginosa. Multiple linear regression (MLR) models 
have been developed as a mathematical equation which can relate chemical structure to the   
inhibitory activity. 
 
2. Results and Discussion 
 
In the first step of the present study, different substituted benzimidazoles (Table 1) were evaluated 
for  in vitro antibacterial activity against Gram-negative Pseudomonas aeruginosa. The inhibitory 
effects of compounds 1 – 14, expressed as minimum inhibitory concentration (MIC) values, are 
summarized in Table 2.  
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Table 1. The structures of the compounds studied. 
N
N
R1
R2
 
Cmpd R1 R 2 Cmpd  R1 R 2 
1  NH2 H  8  CH3 H 
2  NH2  9  CH3 
 
3  NH2  10  CH3 
 
4  NH2 
Cl
11  CH3 
Cl
 
5  NH2 
O
12  CH3 
O  
6  NH2 
O
13  CH3 
O  
7  NH2 
O
Cl
14  CH3 
O
Cl
 
 
Table 2. Antibacterial screening summary. 
Compound  MIC (μg/mL) log1/cMIC 
1  50 3.425 
2  25 3.951 
3  12.5 4.278 
4  6.25 4.615 
5  50 3.676 
6  12.5 4.303 
7  6.25 4.638 
8  100 3.121 
9  50 3.648 
10  25 3.975 
11  12.5 4.312 
12  100 3.373 
13  25 4.000 
14  12.5 4.335 
Ampicillin  12.5 4.446 
Sultamicillin  0.78 5.787 
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The screening results reveal that all the compounds exhibited appreciable in vitro activity against 
the tested strain. In the second step, we focused our efforts on developing the QSAR models of 
compounds  1 – 14 as antibacterial agents. A set of benzimidazoles was used for MLR model 
generation. The reference drugs were not included in model generation as they belong to a different 
structural series. Inhibitory activity data determined as μg/mL were first transformed to the negative 
logarithms of molar MICs (log1/cMIC), (Table 2) which was used as a dependent variable in the QSAR 
study. Different physicochemical, steric, electronic, and structural molecular descriptors were used as 
independent variables and were correlated with antibacterial activity.  
 
Table 3. Values of molecular descriptors used in the regression analysis. 
Cmpd  MR P MV  HE  MW  TE  SAG  DM  ClogP 
1  43.63 15.13  430.33  -11.28  133.15 -1.21 292.48 1.54 -0.61 
2  77.28 26.63  675.88  -7.12  223.28 -9.75 416.78 1.45  0.65 
3  81.56 28.46  728.44  -5.95  237.30 -9.81 442.99 1.53  0.80 
4  81.99 28.55  712.38  -6.72  257.72 -9.81 437.70 1.48  0.43 
5  77.21 26.71  666.31  -7.67  237.29 29.80 409.30 2.16  0.07 
6  81.49 28.55  720.15  -6.52  251.29 29.61 437.71 2.13  0.22 
7  80.61 28.64  710.59  -7.35  271.71 30.38 434.96 2.88  0.44 
8  44.83 15.62  450.85  -4.75  132.16 10.35 304.78 1.36 -0.51 
9  78.48 27.11  693.35  -2.73  222.29 1.34  423.77 1.32  0.75 
10  82.76 28.94  745.41  -1.61  236.32 1.23  453.96 1.45  0.90 
11  83.19 29.04  737.17  -2.44  256.73 1.63  448.98 1.69  0.53 
12  78.41 27.20  686.80  -3.68  236.27 53.89 422.33 2.40  0.17 
13  82.69 29.03  741.13  -2.53  250.30 53.68 452.01 2.42  0.32 
14  81.81 29.12  731.39  -3.36  270.71 54.42 447.07 2.86  0.54 
 
Developing a QSAR model requires a diverse set of data, and, thereby a large number of descriptors 
have to be considered. Descriptors are numerical values that encode different structural features of the 
molecules. Selection of a set of appropriate descriptors from a large number of them requires a 
method, which is able to discriminate between the parameters. Pearson's correlation matrix has been 
performed on all descriptors by using NCSS Statistical Software. The analysis of the matrix revealed 
nine descriptors for the development of MLR model. The values of descriptors selected for MLR 
model are presented in Table 3. Linear models were then formed by a stepwise addition of terms. A 
delition process was then employed, whereby each variable in the model was held out in turn and using 
the remaining parameters models were generated. Each descriptor was chosen as input for the 
statistical software package and then the stepwise addition method implemented in the software was 
used for choosing the descriptors contributing to the antibacterial activity of benzimidazole 
derivatives. 
The specifications for the best-selected MLR models are shown in Table 4. The monoparametric 
model indicated the importance of molar weight (MW) in contribution to inhibitory activity (model 1, 
Table 4). Addition of total energy (TE) as an additional parameter to MW, significantly increased the 
correlation coefficient from 0.7910 to 0.8587 (model 2, Table 4). Similarly, the addition of a third 
parameter also increased the correlation coefficient, but a MLR method only can be used when a Int. J. Mol. Sci. 2009, 10                 
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relatively small number of molecular descriptors are used (at least five to six times smaller than the 
total number of compounds). In this case (for fourteen compounds), only two descriptors can be used 
to develop a good QSAR model in order to avoid a high chance of spurious correlations. In this 
approach, only the QSAR models 1 and 2 can be considered. 
 
Table 4. Best MLR models for the prediction of antibacterial activity. 
Model Coefficient  Error  n r s  F 
1 
Intercept 2.0228  0.4432 
14 0.7910  0.2999  20.053 
MW  0.0085 0.0019 
2 
Intercept 1.88448  0.3965 
14 0.8587  0.2624  15.437  MW  0.0098 0.0018 
TE  -0.0068 0.0031 
 
It is well known that there are three important components in any QSAR study: development of 
models, validation of models and utility of developed models. Validation is a crucial aspect of any 
QSAR analysis [36]. The statistical quality of the resulting models, as depicted in Table 4, is 
determined by r, s, and F [37-39]. It is noteworthy that all these equations were derived using the 
entire data set of compounds (n = 14) and no outliers were identified. The F-value presented in Table 
4 is found statistically significant at 99% level since all the calculated F values are higher as compared 
to tabulated values.  
For the testing the validity of the predictive power of selected MLR models the LOO technique was 
used. The developed models were validated by the calculation of following statistical parameters: 
PRESS, SSY, SPRESS, r
2
CV, and r
2
adj (Table 5). These parameters were calculated from the following 
equations: 
2
) ( PRESS ∑ − = calc obs Y Y   (1) 
2
) ( SSY ∑ − = mean obs Y Y   (2) 
n
PRESS
SPRESS =   (3) 
SSY
PRESS
1
2
CV − = r   (4) 
⎟ ⎟
⎠
⎞
⎜ ⎜
⎝
⎛
− −
−
− =
1
1
) ( 1
2 2
adj p n
n
r r   (5) 
where, Yobs, Ycalc and Ymean are observed, calculated and mean values; n, number of compounds; p, 
number of independent parameters. 
PRESS is an acronym for prediction sum of squares. It is used to validate a regression model with 
regards to predictability. To calculate PRESS, each observation is individually omitted. The remaining 
n – 1 observations are used to calculate a regression and estimate the value of the omitted observation. 
This is done n times, once for each observation. The difference between the actual Y value, yobs, and 
the predicted Y, ycalc, is called the prediction error. The sum of the squared prediction errors is the 
PRESS value. The smaller PRESS is, the better the predictability of the model. Its value being less 
than SSY points out that the model predicts better than chance and can be considered statistically Int. J. Mol. Sci. 2009, 10                 
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significant. SSY are the sums of squares associated with the corresponding sources of variation. These 
values are in terms of the dependent variable, y.  
The PRESS value above can be used to compute an r
2
CV statistic, called r
2 cross validated, which 
reflects the prediction ability of the model. This is a good way to validate the prediction of a regression 
model without selecting another sample or splitting your data. It is very possible to have a high r
2 and 
a very low r
2
CV. When this occurs, it implies that the fitted model is data dependent. This r
2
CV ranges 
from below zero to above one. When outside the range of zero to one, it is truncated to stay within this 
range. Adjusted r-squared (r
2
adj) is an adjusted version of r
2. The adjustment seeks to remove the 
distortion due to a small sample size. 
 
Table 5. Cross-validation parameters. 
Model PRESS  SSY  PRESS/SSY  SPRESS r
2
CV  r
2
adj 
1 1.4444 2.8835  0.5009  0.3212  0.4991  0.5944 
2 1.2609 2.8835  0.4373  0.3001  0.5627  0.6895 
 
In many cases r
2
CV and r
2
adj is taken as a proof of the high predictive ability of QSAR models. A 
high value of these statistical characteristic (> 0.5) is considered as a proof of the high predictive 
ability of the model, although recent reports have proven the opposite [40]. Although a low value of 
r
2
CV for the training set can indeed serve as an indicator of a low predictive ability of a model, the 
opposite is not necessarily true. Indeed, the high r
2
CV does not imply automatically a high predictive 
ability of the model. Thus, the high value of LOO r
2
CV is the necessary condition for a model to have a 
high predictive power, it is not a sufficient condition. It is proven that the only way to estimate the true 
predictive power of a model is to test it on a sufficiently large collection of compounds from an 
external test set. The test set must include no less than five compounds, whose activities and structures 
must cover the range of activities and structures of compounds from the training set. This application 
is necessary for obtaining trustful statistics for comparison between the observed and predicted 
activities for these compounds. Besides high r
2
CV, a reliable model should be also characterized by a 
high correlation coefficient between the predicted and observed activities of compounds from a test set 
of molecules that was not used to develop the models.  
To confirm the predictive power of the QSAR models, an external set of benzimidazoles was used. 
Five benzimidazole derivatives which were tested in our previous paper for their antibacterial activity 
against the Pseudomonas aeruginosa were used as the external set of molecules [33]. In the present 
paper, the inhibitory activity of the following compounds was calculated: 1-(3-methoxybenzyl)-5,6-
dimethylbenzimidazole (15), 1-(3-methylbenzyl)-2-aminobenzimidazole (16), 1-(3-chlorobenzyl)-2-
amino-benzimidazole (17), 1-(3-fluorobenzyl)-2-amino-5,6-dimethylbenzimidazole (18) and 1-(3-
methoxybenzyl)-2-amino-5,6-dimethylbenzimidazole (19).  
The values of inhibitory activitiy of a test set of molecules was calculated with the models 1 and 2. 
These data are compared with experimentally obtained values of antibacterial activity against the same 
bacteria. From the data presented in Table 6, it is shown that high agreement between experimental 
and predicted inhibitory values was obtained (the residual values are small, indicating the good 
predictability of the established models. According to the reference [40], without the validation of the Int. J. Mol. Sci. 2009, 10                 
 
 
1676
4.25 4.30 4.35 4.40
4.0
4.1
4.2
4.3
4.4
4.5
r
2=0.9992
Observed log 1/c
MIC
P
r
e
d
i
c
t
e
d
 
l
o
g
 
1
/
c
M
I
C
Model 1
4.25 4.30 4.35 4.40
4.0
4.1
4.2
4.3
4.4
4.5
r
2=0.9989
Observed log 1/c
MIC
P
r
e
d
i
c
t
e
d
 
l
o
g
 
1
/
c
M
I
C
Model 2
QSAR models by using the external test set, we could not have come to a right conclusion about high 
predictive ability of derived models.  
 
Figure 1. Plots of predicted versus experimentally observed inhibitory activity of 
benzimidazoles against Pseudomonas aeruginosa. 
 
Figure 1 shows the plots of linear regression predicted versus experimental values of the 
antibacterial activity of external set of benzimidazoles. The plots for QSAR models 1 and 2 show a 
very good fit with r
2 = 0.9992 and 0.9989, respectively. It indicates that models 1 and 2 can be 
successfully applied to predict the antibacterial activity of these class of molecules. Moreover, it is not 
possible to use the reported QSAR models to predict the activity of any type of molecules vs. 
Pseudomonas aeruginosa. The applicability domain of the derived QSAR models is the different 
substituted 1-benzyl or 1-benzoylbenzimidazole derivatives. However, it is very important to point out 
an eventual QSAR models disappointments: activity cliffs [41]. It is possible because similar 
molecules can show significantly different biological activities. For these molecules, activities are 
often mispredicted, even when the overall predictivity of the models are high. 
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Comparing the activities of the tested molecules it was found that   
2-aminobenzimidazole derivatives (compounds 1 – 7) were more active than 2-methylbenzimidazoles 
(compounds 8 – 14). It can be concluded that the presence of an amino substituent leads to an increase 
in the activity, in comparison to the presence of a methyl group. Also, the analysis of the results 
indicates that the activity increased in the series of compounds 2 – 3 – 4; 5 – 6 – 7; 9 –10 – 11 and 12 – 
13 – 14. These observations revealed that the nature of the substituents has an effect on inhibitory 
activity. It can be concluded that the presence of substituents (CH3 or Cl) enhanced the activity of the 
compounds 2, 5, 9 and 12. However, the presence of a chloro substituent leads to increase in the 
activity in comparison to the presence of a methyl group. The comparison between antibacterial 
activity of 1-benzyl and 1-benzoylbenzimidazole derivatives showed that they were similar, except in 
the cases of compounds 2 vs. 5, and 9 vs. 12, where the presence of carbonyl group leads to decrease in 
the activity.  
 
Table 6. Predicted log1/cMIC values of benzimidazoles tested against   
Pseudomonas aeruginosa. 
Cmpd log1/cMICexp. 
Model 1  Model 2 
log1/cMIC pred.  Residuals  log1/cMIC pred.  Residuals 
15  4.328 4.287  0.041  4.298  0.030 
16  4.278 4.040  0.238  4.030  0.248 
17  4.314 4.213  0.101  4.233  0.081 
18  4.333 4.312  0.021  4.337  -0.004 
19  4.352 4.414  -0.062  4.442  -0.090 
 
3. Conclusions 
 
From the results and discussion presented above, we conclude that the 2-amino- and 2-
methylbenzimidazole derivatives are effective in vitro against the Gram-negative  bacteria 
Pseudomonas aeruginosa. The results obtained from present investigation of antibacterial activity 
studies indicate that the presence of an amino substituent leads to increase in the activity in 
comparison to the presence of a methyl group. QSAR analysis have been used to study the quantitative 
effects of the molecular structure of the benzimidazoles on their inhibitory activity. Accurate 
mathematical models were developed for predicting the antibacterial activity of this class of 
compounds. The validity of the models have been established by the determination of suitable 
statistical parameters. From the established QSAR models, it was calculated inhibitory activity of the 
external set of benzimidazoles and close agreement between experimental and predicted values was 
obtained. The low residual activity and high cross-validated r
2 values (r
2
CV) observed indicated the 
predictive ability of the developed QSAR models. 
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4. Experimental 
 
4.1. Synthesis of Compounds 
 
All the compounds, were synthesized by a general procedure described by Vlaović [42], except for 
2-aminobenzimidazole (1) and 2-methylbenzimidazole (8), which were of commercially available 
analytical reagent grade. 
 
4.2. Antibacterial Investigations 
 
All the benzimidazole derivatives were tested for their in vitro growth inhibitory activity against the 
Gram-negative  bacteria Pseudomonas aeruginosa (ATCC 27853). Antibacterial activities of the 
compounds were tested by the disc-diffusion method under standard conditions using Mueller-Hinton 
agar medium as described by NCCLS [43]. The investigated isolate of bacteria was seeded in the tubes 
with nutrient broth. Seeded nutrient broth (1 cm
3) was taken and homogenized in tubes with melted 
(45
oC) nutrient agar (9 cm
3). The homogenous suspension was poured in Petri dishes. Filter paper 
discs (diameter 5 mm) were placed on the cooled medium. The investigated compounds (2⋅10
-5dm
3) 
were placed by micropipette on formed solid medium and after incubation for 24 hours in a thermostat 
at 25 – 27
oC, inhibition (sterile) zone diameters (including disc) were measured (in mm). An inhibition 
zone diameter over 8 mm indicates the tested compound is active against microorganism. Every test 
was done in triplicate. 
The MIC measurements were performed by the agar dilution method according to the guidelines 
established by the NCCLS standard M7-A5 [44]. The MIC of tested benzimidazoles is defined as the 
lowest concentration of the compound at which no growth of the strain as observed in a period of time and 
under specified experimental conditions. Stock solutions of the compounds were prepared in DMF. 
Further dilutions were performed with distilled water. The concentration range of the compounds 
tested was between 6.25 – 125μg/mL. The inoculated plates were than incubated at 35
oC for 16-20h. A 
control using DMF without any test compound was included for each organisms. There was no 
inhibitory activity in the wells containing only DMF. The MIC values of the benzimidazoles tested were 
obtained as μg/mL. In order to classify the antibacterial activity, we established comparisons with 
antibacterial agents currently employed in therapeutic treatment. The MICs were compared with 
Ampicillin and Sultamicillin which were screened under similar conditions as reference drugs.  
 
4.3. Molecular Modeling 
 
All molecular modeling studies were performed by using HyperChem 7.5 software (HyperCube Inc, 
Version 7.5) running on a P-III processor [45]. HyperChem includes a model builder that turns a rough 
2D sketch of a molecule into a 3D one. The created 3-D models were cleaned up and subjected to 
energy minimization using MM2. The minimization is executed until the RMS gradient value reaches a 
value smaller than 0.1 kcal/mol⋅A. The Austin Model-1 method was used for re-optimization until the 
RMS gradient attains a value smaller than 0.0001 kcal/mol⋅A using MOPAC. The lowest energy 
structure was used for each molecule to calculate molecular descriptors. Int. J. Mol. Sci. 2009, 10                 
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4.4. Descriptor Generation 
 
The numerical descriptors are responsible for encoding important features of the structure of the 
molecules and can be categorized as electronic, geometric, hydrophobic, and topological characters. 
Descriptors were calculated for each compound in the data set, using the software HyperChem [45] 
and Dragon [46]. Since there was a large number of desriptors for each compound, Pearson's 
correlation matrix was used as a qualitative model, in order to select the suitable descriptors for MLR 
analysis. The nine descriptors which were showing maximum correlation with inhibitory activity were 
chosen for further evaluation. The values of descriptors selected for MLR model are presented in Table 
3 (molar refractivity (MR), polarizability (P), molar volume (MV), hydration energy (HE), molar 
weight (MW), total energy (TE), surface area grid (SAG), dipole moment (DM), and partition 
coefficient (ClogP)).  
 
4.5. Statistical Methods 
 
The complete regression analysis were carried out by PASS 2005, GESS 2006, NCSS Statistical 
Softwares [47]. The ES-SWR algorithm was used to select the most appropriate descriptors. ES-SWR 
is a popular stepwise technique that combines Forward Selection and Backward Elimination. It is 
basically a forward selection approach, but at each step it considers the possibility of deleting a 
variable as in the backward elimination approach, provided that the number of model variables is 
greater than 2.  
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